Clinical Trials Logo

Clinical Trial Summary

The investigators report a case of a 39-year-old man who presented an anterior mediastinal cystic mature teratoma. Those kind of tumor contain elements derived from more than one of the three primary germ layers (ectoderm, mesoderm, endoderm), frequently arranged in a haphazard manner. They arise from totipotent cells and, therefore, are primarily found in gonads, and more rarely in primitive cells kidnapped in other parts of the body. The tissues are immature to well differentiated and foreign to the anatomic site. Mature teratomas are either cystic or solid, although the cystic presentation predominates in gonadal sites. Benign teratomas are the most common mediastinal germ cell tumor, accounting 70% of the mediastinal germ cell tumors in children and 60% of those in adults. Immature teratomas are potentially malignant tumors; their prognosis is influenced by the anatomic site of the tumor, patient age, and the fraction of the tumor that is immature. Treatment of benign mediastinal teratoma includes complete surgical resection, with results in a excellent long-term cure rates. Complete resection of teratomas should be the goal of treatment.


Clinical Trial Description

n/a


Study Design

Observational Model: Case-Only


Related Conditions & MeSH terms


NCT number NCT00836121
Study type Observational
Source Faculdade de Medicina de Catanduva
Contact
Status Completed
Phase N/A
Start date September 2008
Completion date December 2008

See also
  Status Clinical Trial Phase
Active, not recruiting NCT00003643 - Combination Chemotherapy in Treating Men With Germ Cell Cancer Phase 2/Phase 3
Active, not recruiting NCT00104676 - Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors Phase 3
Recruiting NCT00687778 - 11C-Acetate PET/CT Non-FDG-Avid Tumors N/A
Completed NCT00453310 - Sunitinib in Treating Patients With Metastatic Germ Cell Tumors That Have Relapsed or Not Responded to Treatment Phase 2
Completed NCT00470366 - Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors Phase 2
Completed NCT00301782 - Combination Chemotherapy in Treating Male Patients With Germ Cell Tumors Phase 2
Recruiting NCT05179850 - Computer Aided Diagnostic Tool on Computed Tomography Images for Diagnosis of Retroperitoneal Tumor in Children
Recruiting NCT06421805 - Establishing Prospective Mediastinal Tumor Database of PUMCH
Completed NCT02300987 - A Randomized, Blinded, Placebo-controlled, Phase II Trial of LEE011 in Patients With Relapsed, Refractory, Incurable Teratoma With Recent Progression Phase 2
Completed NCT00002931 - Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cell Cancer Phase 2
Completed NCT00432094 - Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors Phase 2
Active, not recruiting NCT02375204 - Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors Phase 3
Completed NCT00423852 - Paclitaxel, Ifosfamide, and Carboplatin Followed By Autologous Stem Cell Transplant in Treating Patients With Germ Cell Tumors That Did Not Respond to Cisplatin Phase 1/Phase 2
Completed NCT00453232 - Combination Chemotherapy and Pegfilgrastim in Treating Men With Metastatic Germ Cell Tumors Phase 2
Recruiting NCT05564026 - Molecular Epidemiology of Pediatric Germ Cell Tumors